Skip to content
Screener

BridgeBio Pharma BBIO Impairment and restructuring

Impairment and restructuring at other companies

Teradyne, Inc. logo
Teradyne, Inc.TER
$3.43M-76.4%
Flex Ltd. logo
Flex Ltd.FLEX
$5M+150%
Starbucks logo
StarbucksSBUX
$25.1M-78.4%
Intel logo
IntelINTC
$4.07B+2,509%
Broadcom Inc. logo
Broadcom Inc.AVGO
$103M-40.1%
Accenture logo
AccentureACN
$0—

Segments

By segment

See full
Reportable Segment$0—

Other financials

Income statement

See full
Revenue$194.5M+66.8%
Gross profit$184.6M+61.9%
Operating income-$106.0M-1.5%
Net income-$166.6M+1.8%
EPS (diluted)-$0.84+4.5%

Balance sheet

See full
Cash & equivalents$882.0M+62.5%
Total debt$3.3B+32,101%
Total equity-$2.3B-38.2%
Total assets$1.4B+55.5%

Cash flow

See full
Operating cash flow-$197.3M+1.0%
CapEx$69.0K—
Free cash flow-$197.3M+0.9%

Valuation

See full
Market cap$16.06B+87.5%
Enterprise value$18.44B+136%
P/S27.7×-8.6×

Profitability

See full
Gross margin95.1%-0.2pp
Operating margin-90.5%-41.2pp
Net margin-125.9%-54.5pp
FCF margin-76.8%—

Returns & leverage

See full
Return on equity-216.8%—
Debt / equity2×—
Current ratio1.5×-3.0×

FAQ

What does impairment and restructuring mean?
Combined charges for asset impairments (write-downs to fair value) and restructuring activities (severance, facility closures, contract terminations).